Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
WO03104250A1
New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
US2004058392A1
Use of novel stem cell markers for isolation of intestinal stem cells, and use of the intestinal stem cells thus obtained for the preparation of a therapeutical composition
US2004033974A1
Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
EP1386639A1
Use of 78 genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer
EP1380644A1
The use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role
